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Human metapneumovirus (HMPV), a member of the family Paramyxoviridae, was first
isolated in 2001. Seroepidemiological studies have shown that HMPV has been a major
etiological agent of acute respiratory infections in humans for more than 50 years.
Molecular epidemiological, genetic, and antigenetic evolutionary studies of HMPV will
strengthen our understanding of the epidemic behavior of the virus and provide valuable
insight for the control of HMPV and the development of vaccines and antiviral drugs
against HMPV infection. In this study, the nucleotide sequence of and genetic variations
in the G gene were analyzed in HMPV strains prevalent in Yokohama City, in the
Kanto area, Japan, between January 2013 and June 2016. As a part of the National
Epidemiological Surveillance of Infectious Diseases, Japan, 1308 clinical specimens
(throat swabs, nasal swabs, nasal secretions, and nasal aspirate fluids) collected at
24 hospitals or clinics in Yokohama City were screened for 15 major respiratory viruses
with a multiplex reverse transcription–PCR assay. HMPV was detected in 91 specimens,
accounting for 7.0% of the total specimens, and the nucleotide sequences of the
G genes of 84 HMPV strains were determined. Among these 84 strains, 6, 43, 10,
and 25 strains were classified into subgroups A2a, A2b, B1, and B2, respectively.
Approximately half the HMPV A2b subgroup strains detected since 2014 had a 180-
nucleotide duplication (180nt-dup) in the G gene and clustered on a phylogenic tree
with four classical 180nt-dup-lacking HMPV A2b strains prevalent between 2014 and
2015. The 180nt-dup causes a 60-amino-acid duplication (60aa-dup) in the G protein,
creating 23–25 additional potential acceptor sites for O-linked sugars. Our data suggest
that 180nt-dup occurred between 2011 and 2013 and that HMPV A2b strains with
180nt-dup (A2b180nt−dup HMPV) became major epidemic strains within 3 years. The
detailed mechanism by which the A2b180nt−dup HMPV strains gained an advantage that
allowed their efficient spread in the community and the effects of 60aa-dup on HMPV
virulence must be clarified.
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INTRODUCTION
The aim of this study was to strengthen our understanding of
the epidemic behavior of Human metapneumovirus (HMPV)
by providing virological data on the distribution patterns of
HMPV. HMPV was first isolated in 2001 from young children
suffering acute respiratory infections (ARIs), and was classified
in the subfamily Pneumovirinae in the family Paramyxoviridae
(van den Hoogen et al., 2001). Seroepidemiological studies have
shown that the virus has been circulating globally for more
than 50 years (van den Hoogen et al., 2001). HMPV is a
major cause of upper and lower ARIs in infants and children
(Collins and Karron, 2013), and also causes severe ARIs in
aged adults and patients with underlying diseases (Boivin et al.,
2002; Stockton et al., 2002; Falsey et al., 2003). Most children
experience their first infection with HMPV before 5 years of
age, but this infection does not provide lifelong immunity, and
reinfection occurs frequently (van den Hoogen et al., 2001;
Ebihara et al., 2004). In Japan, epidemics of HMPV have occurred
between January and June, and especially in March and April
(Kaida et al., 2006; Mizuta et al., 2010, 2013; Nakamura et al.,
2013).
HMPV has a non-segmented negative-strand RNA genome of
∼13 kb. The HMPV genome contains eight genes in the order:
3′-N–P–M–F–M2–SH–G–L-5′ (Collins and Karron, 2013). The
virus has three types of transmembrane viral proteins in its
envelope, the fusion (F) protein, small hydrophobic (SH) protein,
and glycoprotein (G protein), which are encoded by the F,
SH, and G genes, respectively (Collins and Karron, 2013). The
F protein is responsible for viral attachment and membrane
fusion and is essential for viral infectivity (Biacchesi et al.,
2004, 2005). Cell-surface integrins and glycosaminoglycans play
roles in viral attachment and membrane fusion, mediated by
the F protein (Cseke et al., 2009; Chang et al., 2012; Cox
et al., 2012, 2015). The SH protein has properties consistent
with those of viroporins and modulates the viral fusogenic
activity (Masante et al., 2014). The G proteins of some lineages
of HMPV also bind to glycosaminoglycans and contribute to
HMPV infection (Thammawat et al., 2008; Adamson et al.,
2012, 2013). The short cytoplasmic domain of the G protein
inhibits the RIG-I-dependent signaling pathways (Bao et al.,
2008). Despite these roles, the G and SH proteins are not essential
for viral infectivity, but function as virulence factors (Biacchesi
et al., 2004, 2005). Therefore, the G protein can be targeted
in the development of antiviral drugs. The F protein is highly
immunogenic and induces protective immunity, whereas the G
and SH proteins are poorly immunogenic (Skiadopoulos et al.,
2006).
The G protein is the most variable of the HMPV proteins,
and mutations predominantly accumulate in the extracellular
domain (Peret et al., 2004). The G protein has multiple
potential glycosylation sites, and glycosylation can modify its
immunogenicity (Liu et al., 2007). An evolutionary analysis
of HMPV suggested that selective pressure is exerted on the
G protein by the host’s adaptive immunity (Gaunt et al.,
2011). HMPV is divided to two groups, A and B, based
on variations in its nucleotide sequence and its reactivity to
monoclonal antibodies (van den Hoogen et al., 2004). The
G gene has the most variable nucleotide sequence, and each
viral group is further divided to two subgroups, A1 and A2
in group A, and B1 and B2 in group B, based mainly on
the variations in the G gene (Biacchesi et al., 2003; van den
Hoogen et al., 2004). Further detailed analyses of HMPV
strains have also suggested two clades in the A2 subgroup,
A2a and A2b (Huck et al., 2006). These different subgroups
of HMPV have been detected in varying proportions in
different countries and regions. In this study, we identified
the genetic variations in the G gene of the HMPV strains
prevalent in Yokohama City, in the Kanto area, Japan, between
January 2013 and June 2016. Our data demonstrate a 180-
nucleotide (nt) duplication (180nt-dup) in the G gene of
HMPV and suggest that 180nt-dup occurred between 2011
and 2013. The HMPV A2b strains containing 180nt-dup
(A2b180nt−dup HMPV strains) became major epidemic strains
within 3 years, possibly overwhelming the classical A2b HMPV
strains.
MATERIALS AND METHODS
Clinical Samples and HMPV Detection
In Yokohama City between January 2013 and June 2016,
1308 clinical specimens (throat swabs, nasal swabs, nasal
secretions, and nasal aspirate fluids) were collected from
patients suffering upper or lower ARIs in 16 sentinel hospitals
and clinics (eight pediatric clinics, four internal medicine
clinics, and four hospitals) participating in the National
Epidemiological Surveillance of Infectious Diseases (NESID),
instituted by the Infectious Diseases Control Law in Japan,
and in eight other medical institutions (one pediatric clinic
and seven hospitals) (Anon, 2010). There were 113 hospitals
and 2962 clinics in Yokohama City, and the population in
the city was ∼3.7 million. Thus, the numbers of hospitals
and clinics participated in this study were ∼9.7 and ∼0.4%,
respectively, in the city. Before collecting the clinical specimens
in which to analyze the viruses causing ARIs, the physicians
at each medical institution obtained the informed consent
of the patients or their guardians. The de-identified clinical
specimens were sent to Yokohama City Institute of Public
Health and subjected to multiplex RT–PCR with the Seeplex R©
RV15 OneStep ACE Detection kit (Seegene, Seoul, South
Korea), which identifies 15 major respiratory viruses. The
clinical specimens that were positive for HMPV were analyzed
further.
RNA Extraction and RT–PCR
The RNAs were purified from clinical specimens (140 µl) using
the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany),
according to the manufacturer’s instruction, and dissolved in
60 µl of distilled water. The RNA in 5 µl of the purified
RNA solution was reverse transcribed, and the G gene was
amplified from the cDNA with RT–PCR using the PrimeScript
II High Fidelity One Step RT–PCR Kit (TaKaRa Bio, Otsu,
Japan) and a pair of G-gene-specific primers, SH7 (5′ primer)
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(van den Hoogen et al., 2004) and GR (3′ primer) (Banerjee et al.,
2011). The reaction mixture was prepared in a 50 µl solution,
and the reverse-transcription reaction was performed at 45◦C
for 10 min. The reverse transcriptase was inactivated at 94◦C
for 2 min. The G gene cDNA was amplified with PCR with 40
cycles of 10 s at 98◦C, 15 s at 56◦C, and 10 s at 68◦C. The cDNA
products were separated electrophoretically in 3% NuSieveTM
3:1 Agarose gel in 0.5% TBE buffer. When no G-gene-specific
band was detected or was only barely detectable, 5 µl of the
RT–PCR product was subjected to semi nested PCR. In this
assay, the reaction mixture was prepared in a 50 µl solution,
and the RT–PCR products were denatured at 94◦C for 2 min.
The G gene was then PCR amplified with 40 cycles of 10 s
at 98◦C, 15 s at 50◦C, and 30 s at 68◦C with Tks GflexTM
DNA Polymerase (TaKaRa Bio) and a pair of G-gene-specific
primers, SH7 (5′ primer) and GNR2 (3′ primer). The sequence
of the GNR2 primer was 5′-GGATTCATTAAGAGGATCCA
TTG-3′. The products of the semi nested PCR were separated
electrophoretically to detect the G gene.
Sequencing
The nucleotide sequences of the G gene of the HMPV strains
were determined with direct sequencing. The amplified HMPV
G genes were purified with the QIAquick PCR Purification Kit
(Qiagen). The PCR products were subjected to cycle sequencing
with the BigDye Terminator ver. 1.1 Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA, USA) and the SH7,
GR, and GNR2 primers. The products of the cycle sequencing
reactions were purified through Centri-Sep Spin Columns
(Thermo Fisher Scientific), and the nucleotide sequences were
determined with a 3500 Genetic Analyzer (Applied Biosystems).
The nucleotide sequence data for the HMPV strains were
aligned and edited with the BioEdit software (ver. 7.2.5) (Hall,
1999).
Phylogenetic Analysis
A multiple-sequence alignment was constructed with the
MAFFT software (ver. 7.304b) using the default settings (Katoh
et al., 2002). Phylogenetic analyses were performed with the
maximum likelihood method in the MEGA software (ver.
7.0.20) (Kumar et al., 2016), and the statistical significance
of the tree topologies was tested with bootstrapping (50
replicates).
N- and O-Glycosylation Site Analysis
Potential acceptor sites for N- and O-linked sugars were




The nucleotide sequence data reported in the present study were
deposited in the DDBJ/EMBL/GenBank nucleotide sequence
database under accession numbers LC192170–LC192253.
Estimating the Evolutionary Rate of the
HMPV G Gene
The overall rate of evolutionary change (nucleotide substitutions
per site per year) in the HMPV G gene was estimated with the
BEAST 2 program3, which uses a Bayesian Markov Chain Monte
Carlo (MCMC) approach (BEAST 2: A Software Platform for
Bayesian Evolutionary Analysis4). An aligned G gene sequence
dataset from the 84 HMPV strains detected in Yokohama City
from 2013 to 2016 was analyzed with the BEAST 2 program using
a strict HKY model. The MCMC chain was run for a sufficient
length of time to ensure convergence (all expected sample size
values exceeded 200 with a 10% burn-in).
Ethics Statement
These analyses have been done as a part of the National
Epidemiological Surveillance of Infectious Diseases, Japan
(NESID) as stipulated under the Infectious Diseases Control
Law, and before collecting the clinical specimens, physicians in
each medical institution obtained the informed consent of the
patients or their guardians. The ethics committee of Yokohama
City Institute of Public Health approved this study.
Prediction of the Year in Which
180nt-dup Occurred in the HMPV
Genome
The consensus nucleotide sequence was determined using both





TABLE 1 | Characteristics of patientsa infected with Human metapneumovirus (HMPV) strains.
A2a A2b A2b180nt−dup B1 B2
Ageb (year) 4.8 (2.2–5.2) 3.3 (1.8–6.5) 1.8 (1.4–6.4) 2.1 (1.3–4.4) 2.6 (1.3–4.7)
Sexc
Female 3 10 4 6 7
Male 3 14 8 3 15
Body temperatured 39.1 (1.3) 38.6 (2.3) 39.4 (0.7) 38.7 (1.2) 39.7 (0.7)
aOf the total 84 patients, clinical information was available for 73 patients.
bData are medians (interquartile ranges).
cNumber of patients.
dMean (standard deviation).
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FIGURE 1 | Phylogenetic tree of 574 Human metapneumovirus (HMPV) strains, constructed with the maximum likelihood method. A phylogenetic tree
was constructed from the G gene sequences of 84 HMPV strains and all other available HMPV G gene sequences. In total, 574 G gene sequences of HMPV strains
were included. The HMPV A2b subgroup strains containing a 180-nt duplication (180nt-dup) in the G gene (A2b180nt−dup HMPV) are shown in cyan boxes and the
other HMPV strains detected in Yokohama City between January 2013 and June 2016 are shown in orange boxes.
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TABLE 2 | Numbers of HMPV strains detected in Yokohama City between
January 2013 and June 2016 and their subgroup classification.
180nt-dupa Year of virus detection Total
Subgroup 2013 2014 2015 2016
A2a − 4 1 1 0 6
A2b − 11 3 12 2 28
+ 0 3 10 2 15
B1 − 2 2 1 5 10
B2 − 14 6 0 5 25
Total 31 15 24 14 84
a180-nt duplication.
180-nucleotide sequence (2nd-180nts) in the 15 A2b180nt−dup
HMPV strains (in total, 30 sequences of 180 nt) and was assumed
to be the corresponding 180 nt of the hypothetical ancestral
strain of the 15 A2b180nt−dup HMPV strains. The number of
nucleotide substitutions in the 1st- and 2nd-180nts of each
A2b180nt−dup HMPV strain was determined and compared with
the corresponding 180 nt of the hypothetical ancestral strain, and
the year in which 180nt-dup occurred in the HMPV genome was
estimated based on the mean rate of nucleotide substitutions for
the HMPV G gene.
RESULTS
Nucleotide Sequence and Phylogenetic
Analyses
Human metapneumovirus was detected in 91 of 1308 specimens
from ARI patients, accounting for 7.0% of the specimens.
The basic and clinical characteristics of the patients infected
with HMPV are summarized in Table 1. The entire nucleotide
sequences of the open reading frames of the G proteins were
determined for 84 of the 91 HMPV strains. These 84 HMPV
strains had 73 unique G gene sequences, containing at least
one nucleotide substitution, whereas the remaining 11 sequences
were identical to other G gene sequences. A phylogenetic
analysis was performed using the G gene sequences of the 84
HMPV strains and all the HMPV G gene sequences available
at the National Center for Biotechnology Information (NCBI)
nucleotide sequence database5. In total, 574 G gene sequences
of HMPV strains were used to construct the phylogenetic tree
(Figure 1). Among our 84 strains, 6, 43, 10, and 25 strains
were classified in subgroups A2a, A2b, B1, and B2, respectively
(Figure 1). No HMPV strain belonged to subgroup A1. These
data are similar to previous findings in Japan (Matsuzaki et al.,
2008; Mizuta et al., 2010; Toda et al., 2010; Omura et al.,
2011; Nidaira et al., 2012; Nakamura et al., 2013). Table 2
shows the numbers of HMPV strains detected between January
2013 and June 2016 in Yokohama City and their subgroup
classification. Multiple subgroup strains were detected in each
year. Subgroup A2b strains were detected every year, and
approximately half the A2b subgroup strains detected in 2014,
5https://www.ncbi.nlm.nih.gov/nucleotide/
FIGURE 2 | Nucleotide sequence alignment of HMPV strains. An
alignment of the plus-sense nucleotide sequences of the 180-nt duplicated
regions and adjacent regions of the HMPV G genes of 15 A2b180nt−dup HMPV
strains, the hypothetical ancestral strain (Ancestor), and a representative
classical A2b strain (P7015) is shown. The first 180-nt region (1st-180nt) and
the second 180-nt region (2nd-180nt) are shown in green and pink boxes,
respectively. The first nucleotide of the initiation codon of the G gene is
deemed to be nucleotide position 1. The nucleotide sequence of the
hypothetical ancestral strain was predicted by constructing a consensus
sequence of the duplicated 180-nt sequences of all 15 A2b180nt−dup HMPV
strains. Dots indicate nucleotides identical to those of the hypothetical
ancestral strain. Hyphens in yellow boxes indicate gaps in the sequence.
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FIGURE 3 | Phylogenetic tree constructed with 1st-180nt and 2nd-180nt in the duplicated region of 15 A2b180nt−dup HMPV strains. The duplicated
region contains the original 1st-180nt and the duplicated 2nd-180nt. A phylogenetic tree was constructed from the 1st- and 2nd-180nts of 15 A2b180nt−dup HMPV
strains, and the tree was rooted with HMPV A2a strain HMPV/Yokohama.JPN/P7011/2013. The labels at the branch nodes indicate their statistical significance,
calculated with bootstrapping (50 replicates).
2015, and 2016 contained 180nt-dup in the G gene (Figure 2).
180nt-dup is a duplication of the 180 nt at nucleotide positions
371–550 (the first nucleotide of the initiation codon of the G
gene is deemed to be nucleotide position 1). No A2b strain
detected in 2013 contained 180nt-dup. The 15 A2b180nt−dup
HMPV strains formed a small cluster on the phylogenetic tree
(Figure 1), and the cluster also contained four classical A2b
strains, which lack 180nt-dup and were detected in 2014 and
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FIGURE 4 | Deduced amino acid sequence of A2b180nt−dup HMPV strain. A plus-sense nucleotide (nt) sequence alignment of a representative A2b180nt−dup
HMPV strain (P7450) and a classical A2b HMPV strain (P7015), together with their deduced amino acid (aa) sequences, are shown. The 1st-180nt and 2nd-180nt
regions are shown in green and pink boxes, respectively. The first nucleotide of the initiation codon of the G gene is deemed to be nucleotide position 1. Dots
indicate nucleotides identical to those in the hypothetical ancestral strain. Hyphens in yellow boxes indicate gaps in the sequence.
2015 in Yokohama City. These data suggest that 180nt-dup
occurred in a specific ancestor of the HMPV strains in this cluster
(Figure 2).
Prediction of the Year in Which
180nt-dup Occurred
Although the 15 A2b180nt−dup HMPV strains seemed to be
derived from a common ancestor, the 180nt-dup sequences of
most A2b180nt−dup HMPV strains differed from one another
(Figure 2). Even within the same viral genome, the 1st-
180nt differed from the 2nd-180nt by one to six nucleotide
substitutions. These observations were not unexpected, because
substitutions would have occurred in each viral genome
after the ancestral A2b strain had acquired 180nt-dup. RNA
viruses are vulnerable to changes in their nucleotide sequences
because the viral RNA-dependent RNA polymerase (RdRp)
lacks proofreading activity. Therefore, the original 180-nt
sequence in the hypothetical ancestral strain was predicted by
constructing a consensus sequence of the 1st- and 2nd-180nts
of the 15 A2b180nt−dup HMPV strains (Figure 2). The 360-nt
sequence, consisting of the 1st- and 2nd-180nts of each of
the 15 A2b180nt−dup HMPV strains, was then compared with
that of the hypothetical ancestral strain (Figure 2). In the
1st-180nt, strain HMPV/Yokohama.JPN/P7916/2015 had the
same nucleotide sequence as the ancestral strain, whereas the
other 14 strains had one to six nucleotide substitutions relative
to the sequence of the ancestral strain (Figure 2). In the 2nd-
180nt, two strains (HMPV/Yokohama.JPN/P7450/2014 and
HMPV/Yokohama.JPN/P7875/2015) had the same nucleotide
sequence as the ancestral strain, whereas the other 13 strains
had one to six nucleotide substitutions relative to the sequence
of the ancestral strain (Figure 2). We then estimated the
evolutionary rate of the HMPV G gene with the BEAST 2
program to predict the year in which 180nt-dup occurred. The
evolutionary rate was estimated to be 4.3 × 10−3/site/year
(95% highest probability density: 3.2–5.4 × 10−3/site/year),
consistent with the rate previously estimated by de Graaf
et al. (2008). Based on these data, 180nt-dup was predicted to
have occurred in the ancestral strain between 2011 and 2013.
Figure 3 shows a phylogenetic tree constructed with the 15
1st-180nts and the 15 2nd-180nts. The tree was rooted with
the HMPV A2a strain HMPV/Yokohama.JPN/P7011/2013.
Theoretically, the 1st- and 2nd-180nts in each strain should be
identical at the time when the duplication occurred. However,
among the 15 A2b180nt−dup HMPV strains, the 1st- and 2nd-
180nts of 13 strains have diverged randomly and the 1st- and
2nd-180nts of each of these 13 strains were not located in the
same cluster. These data suggest that these 13 strains had the
same ancestral strain but acquired nucleotide substitutions
in both the 1st- and 2nd-180nts independently of each other.
In contrast, the 1st- and 2nd-180nts of two A2b180nt−dup
HMPV strains, HMPV/Yokohama.JPN/P7886/2015 and
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FIGURE 5 | Amino acid sequence alignment of HMPV strains. Aligned amino acid sequences derived from the HMPV G genes of 15 A2b180nt−dup HMPV
strains, the hypothetical ancestral strain (Ancestor), and a representative classical A2b strain (P7015) are shown. The region between amino acid (aa) 1–30 is the
cytoplasmic tail (CT) domain, and the region between aa 31–53 is the transmembrane (TM) domain. The remaining region is the extracellular ectodomain (EE). The
1st-180nt and 2nd-180nt regions are shown in green and pink boxes, respectively. The amino acid sequence of the hypothetical ancestral strain was predicted by
constructing a consensus sequence of all 15 A2b180nt−dup HMPV strains. Dots indicate amino acids identical to those of the hypothetical ancestral strain. Hyphens
in yellow boxes indicate gaps in the sequence.
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HMPV/Yokohama.JPN/P7929/2015, were located in a distinct
small cluster on the phylogenetic tree, suggesting that these
two A2b180nt−dup HMPV strains had a different ancestral
strain.
Deduced G-Protein Amino Acid
Sequences of A2b180nt−dup HMPV Strains
Figure 4 shows a nucleotide sequence alignment of a
representative A2b180nt−dup HMPV strain (HMPV/Yokohama.
JPN/P7450/2014) and a classical A2b HMPV strain
(HMPV/Yokohama.JPN/P7015/2013), and their deduced
amino acid sequences. Figure 5 shows amino acid sequence
alignment of the G protein of 15 A2b180nt−dup HMPV strains,
the hypothetical ancestral strain, and the representative classical
A2b strain (HMPV/Yokohama.JPN/P7015/2013). Compared
with the classical A2b strain, the A2b180nt−dup strains have a
60-amino-acid duplication (60aa-dup) in the G protein. Because
the 180-nt region at positions 371–550 is duplicated, a codon
(AGG) for arginine encoded at nucleotide positions 550–552
is replaced with a codon (ACA) for threonine (nucleotides in
the duplicated sequence are underlined; the first nucleotide of
the initiation codon of the G gene is deemed to be nucleotide
position 1), which is followed by the duplicated nucleotide
sequence encoding 60aa-dup (Figure 4). The 60aa-dup is
located in the C-terminal half of the extracellular ectodomain
(Figure 5) and contains many potential acceptor sites for
O-linked sugars. The G protein of the classical A2b strains, which
lack 60aa-dup, have 58–63 potential acceptor sites for O-linked
sugars. With 60aa-dup, the G proteins of the A2b180nt−dup
HMPV strains have acquired 23–25 additional potential
acceptor sites for O-linked sugars. However, 60aa-dup does
not affect the number of potential acceptor sites for N-linked
sugars.
DISCUSSION
In the present study, we determined the G gene sequences of
84 HMPV strains detected in Yokohama City between January
2013 and June 2016. Our data demonstrate that HMPV strains
of the four subgroups A2a, A2b, B1, and B2 were prevalent in
Yokohama City in this period. Most importantly, the analysis
detected 180nt-dup in the G genes of circulating HMPV A2b
strains. Among the 32 A2b strains detected in Yokohama between
2014 and 2016, 15 (46.9%) contained 180nt-dup. Because 180nt-
dup does not cause a frameshift in the G mRNA sequence,
it generates the 60aa-dup in the G protein. A previous study
(Leyrat et al., 2014) suggested that the extracellular ectodomain
of the HMPV G protein sterically shields the F protein from
recognition by host immune factors. These additional 60 amino
acids may enhance this steric inhibition effect. The additional
potential acceptor sites for O-linked sugars in the 60aa-dup
region may also contribute to the evasion of immune recognition
by the host, as has been observed for Ebola virus (Francica et al.,
2010).
Similar duplications in the G gene have been reported
in Respiratory syncytial virus (RSV), another member of the
subfamily Pneumovirinae in the family Paramyxoviridae. A
72-nt duplication (72nt-dup) was detected in the G gene of
genotype ON1 RSV strains in subgroup A (Eshaghi et al.,
2012). A 60-nt duplication (60nt-dup) was also detected in
the G gene of the genotype BA RSV strains in subgroup B
(Trento et al., 2003). When we searched the currently available
nucleotide sequence databases of viruses, we found no HMPV
strain with a sequence duplication in the G gene. However,
during the preparation of this manuscript, a similar report
of 180nt-dup was presented at the 19th Annual Meeting of
the European Society for Clinical Virology held in September
2016 (Pinana et al., 2016). Although only the abstract of the
study is available, the study identified nine HMPV strains
with 180nt-dup among 52 A2b strains detected in Barcelona,
Spain, between 2014 and 2016 (Pinana et al., 2016). That study
suggests that the virulence of the nine HMPV strains containing
180nt-dup was elevated based on the clinical manifestations
of the children infected with those HMPV strains (Pinana
et al., 2016). No such clinical differences were evident in our
data.
Our data suggest that 180nt-dup occurred between 2011 and
2013. Importantly, these A2b180nt−dup HMPV strains became
some of the major strains circulating in Yokohama City within
3 years. However, further surveillance data are required to
determine whether these novel HMPV A2b strains persist as
predominant strains. An increased frequency of A2b180nt−dup
HMPV strains among the A2b strains was also observed in
Barcelona, Spain (Pinana et al., 2016). Together, these data
suggest that A2b180nt−dup HMPV strains are already circulating
globally.
Although similar duplications in the G gene have been
observed in RSV, the size of the duplication in the A2b180nt−dup
HMPV strains is 2–3 times larger than that observed in the
RSV G gene. Therefore, 60aa-dup, which results from 180nt-
dup, may alter the viral antigenicity and the G protein functions
more dramatically than the duplications observed in the RSV
G gene. No significant difference in virulence was observed in
the genotype ON1 and BA RSV strains when they acquired
72nt-dup and 60nt-dup, respectively, in their G genes (Sato
et al., 2005; Tabatabai et al., 2014). However, these strains have
spread rapidly and globally, and are currently the predominant
strains in many countries (Trento et al., 2006; Duvvuri et al.,
2015). Our data suggest that within 3 years, the A2b180nt−dup
HMPV strains became one of the major strains of this pathogen.
The mechanism by which the A2b180nt−dup HMPV strains gain
an advantage over other strains when spreading in human
populations, possibly by overwhelming the classical strains, and
the effects of 180nt-dup in the G gene on HMPV virulence must
be clarified.
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